• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他米沙坦-氨基酸共无定形制剂的制备与评价:一种提高溶解度和溶出度的潜在方法。

Preparation and Evaluation of Co-amorphous Formulations of Telmisartan-Amino Acids as a Potential Method for Solubility and Dissolution Enhancement.

机构信息

Department of Pharmaceutical Technology, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.

Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy and Medical Sciences, Petra University, Amman, Jordan.

出版信息

AAPS PharmSciTech. 2021 Mar 21;22(3):112. doi: 10.1208/s12249-021-01952-9.

DOI:10.1208/s12249-021-01952-9
PMID:33748914
Abstract

Telmisartan (TLM) is a potent antihypertensive drug with pH-dependent aqueous solubility. This work aimed to enhance the solubility and dissolution rate of TLM by the co-amorphous drug amino acid (AA) approach by combining TLM, with different types and ratios of AAs. The co-amorphous TLM-AA blends were prepared by freeze-drying and investigated for solid-state characteristics like the dissolution rate enhancement of TLM. Among the prepared co-amorphous formulations, TLM-arginine (ARG) exhibited the greatest enhancement in solubility with increasing the molar ratio of ARG. The TLM-ARG at 1:2 ratio showed about a 57-fold increase in solubility of TLM and the highest dissolution percentage in phosphate buffer (pH7.5) (100% in 20 minutes) compared to both crystalline TLM (20% in 60 min) and physical mixture. Powder XRD, DSC, FTIR analysis and SEM demonstrated the formation of amorphous form within the co-amorphous formulations. Only TLM:ARG (1:0.5) were stable at (40°C, 75% RH) for a minimum of 90 days. In conclusion, ARG was able to stabilize the amorphous form of TLM and enhances its aqueous solubility and dissolution. The 1:2 w/w ratio of TLM-ARG co-amorphous showed the best solubility and dissolution rate while the 1:0.5 w/w ratio showed the best stability.

摘要

替米沙坦(TLM)是一种具有 pH 依赖性水溶度的强效降压药物。本工作旨在通过共无定形药物氨基酸(AA)方法来提高 TLM 的溶解度和溶解速率,将 TLM 与不同类型和比例的 AA 结合。通过冷冻干燥制备共无定形 TLM-AA 混合物,并对其进行固态特性研究,如 TLM 的溶解速率增强。在所制备的共无定形配方中,TLM-精氨酸(ARG)在增加 ARG 摩尔比时表现出最大的溶解度提高。TLM-ARG 为 1:2 比例时,TLM 的溶解度提高了约 57 倍,在磷酸盐缓冲液(pH7.5)中的溶解百分比最高(20 分钟内为 100%),与结晶 TLM(60 分钟内为 20%)和物理混合物相比。粉末 XRD、DSC、FTIR 分析和 SEM 表明共无定形配方中形成了无定形形式。只有 TLM:ARG(1:0.5)在(40°C,75%RH)下至少 90 天稳定。总之,ARG 能够稳定 TLM 的无定形形式并提高其水溶解度和溶解速率。TLM-ARG 共无定形的 1:2 w/w 比例显示出最佳的溶解度和溶解速率,而 1:0.5 w/w 比例显示出最佳的稳定性。

相似文献

1
Preparation and Evaluation of Co-amorphous Formulations of Telmisartan-Amino Acids as a Potential Method for Solubility and Dissolution Enhancement.他米沙坦-氨基酸共无定形制剂的制备与评价:一种提高溶解度和溶出度的潜在方法。
AAPS PharmSciTech. 2021 Mar 21;22(3):112. doi: 10.1208/s12249-021-01952-9.
2
Effect of amorphization method on telmisartan solubility and the tableting process.非晶化方法对替米沙坦溶解度和压片工艺的影响。
Eur J Pharm Biopharm. 2013 Jan;83(1):114-21. doi: 10.1016/j.ejpb.2012.09.019. Epub 2012 Oct 17.
3
Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.喷雾干燥共无定形药物 - 氨基酸盐的制备与表征
J Pharm Pharmacol. 2016 May;68(5):615-24. doi: 10.1111/jphp.12458. Epub 2015 Aug 5.
4
Co-former selection for co-amorphous drug-amino acid formulations.共无定形药物-氨基酸制剂共晶形成剂的选择。
Int J Pharm. 2019 Feb 25;557:366-373. doi: 10.1016/j.ijpharm.2018.12.036. Epub 2018 Dec 19.
5
Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.喷雾干燥技术制备和评价替米沙坦 pH 调节固体分散体。
Int J Pharm. 2013 Jan 30;441(1-2):424-32. doi: 10.1016/j.ijpharm.2012.11.012. Epub 2012 Nov 19.
6
Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.氨基酸作为低水溶解性药物的共无定形稳定剂——第 1 部分:制备、稳定性和溶出度的提高。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):873-81. doi: 10.1016/j.ejpb.2013.03.014. Epub 2013 Mar 26.
7
Co-milling of telmisartan with poly(vinyl alcohol)--An alkalinizer free green approach to ensure its bioavailability.替米沙坦与聚乙烯醇的共研磨——一种无碱化剂的绿色方法以确保其生物利用度。
Eur J Pharm Biopharm. 2016 Apr;101:43-52. doi: 10.1016/j.ejpb.2016.01.016. Epub 2016 Jan 29.
8
Permeability of glibenclamide through a PAMPA membrane: The effect of co-amorphization.格列本脲经 PAMPA 膜的渗透:共无定形化的影响。
Eur J Pharm Biopharm. 2018 Aug;129:247-256. doi: 10.1016/j.ejpb.2018.06.007. Epub 2018 Jun 9.
9
Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan.氨基酸作为共无定形辅料用于解决缬沙坦水溶性差的问题。
Pharm Dev Technol. 2017 Feb;22(1):69-76. doi: 10.3109/10837450.2016.1163390. Epub 2016 Apr 6.
10
Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.制备无定形呋塞米钠盐可提高溶解度和溶出速率,并导致大鼠口服给药后的 Tmax 更快。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):942-51. doi: 10.1016/j.ejpb.2013.09.002. Epub 2013 Sep 27.

引用本文的文献

1
Cutting-Edge Approaches in the Co-Amorphization Process.共非晶化过程中的前沿方法。
Pharmaceutics. 2025 Jun 29;17(7):850. doi: 10.3390/pharmaceutics17070850.
2
Biofunctional Excipients: Their Emerging Role in Overcoming the Inherent Poor Biopharmaceutical Characteristics of Drugs.生物功能性辅料:它们在克服药物固有的不良生物药剂学特性方面的新兴作用。
Pharmaceutics. 2025 May 1;17(5):598. doi: 10.3390/pharmaceutics17050598.
3
Microwave coprocessing of modafinil with Gelucire: Thermal and compression characteristics.莫达非尼与Gelucire的微波共处理:热特性和压缩特性。

本文引用的文献

1
Improving the Dissolution of Triclabendazole from Stable Crystalline Solid Dispersions Formulated for Oral Delivery.提高稳定结晶固体分散体中三氯苯达唑的溶出度,用于口服给药。
AAPS PharmSciTech. 2019 Dec 5;21(1):16. doi: 10.1208/s12249-019-1551-4.
2
Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations.壳聚糖基纳米递药系统在新型三氯苯达唑制剂开发中的应用。
PLoS One. 2018 Dec 12;13(12):e0207625. doi: 10.1371/journal.pone.0207625. eCollection 2018.
3
Development of Microemulsions and Microemulgels for Enhancing Transdermal Delivery of Kaempferia parviflora Extract.
ADMET DMPK. 2025 Jan 19;13(1):2569. doi: 10.5599/admet.2569. eCollection 2025.
4
Curcumin Solubility and Bioactivity Enhancement Through Amorphization with Tryptophan via Supercritical Fluid Technology.通过超临界流体技术与色氨酸非晶化提高姜黄素的溶解度和生物活性
Int J Mol Sci. 2025 Jan 20;26(2):855. doi: 10.3390/ijms26020855.
5
Multicomponent Amorphous Solid Forms of Telmisartan: Insights into Mechanochemical Activation and Physicochemical Attributes.替米沙坦的多组分无定形固体形式:机械化学活化与物理化学性质的深入研究。
AAPS PharmSciTech. 2024 Apr 11;25(4):84. doi: 10.1208/s12249-024-02799-6.
6
Genistein Co-Amorphous Systems with Amino Acids: An Investigation into Enhanced Solubility and Biological Activity.染料木黄酮与氨基酸的共无定形体系:关于溶解度增强及生物活性的研究
Pharmaceutics. 2023 Nov 21;15(12):2653. doi: 10.3390/pharmaceutics15122653.
7
Sinapic Acid Co-Amorphous Systems with Amino Acids for Improved Solubility and Antioxidant Activity.与氨基酸形成的咖啡酸共无定形系统,提高了溶解度和抗氧化活性。
Int J Mol Sci. 2023 Mar 14;24(6):5533. doi: 10.3390/ijms24065533.
8
Data-Driven Prediction of the Formation of Co-Amorphous Systems.基于数据驱动的共无定形体系形成预测
Pharmaceutics. 2023 Jan 20;15(2):347. doi: 10.3390/pharmaceutics15020347.
9
Amorphous and Co-Amorphous Olanzapine Stability in Formulations Intended for Wet Granulation and Pelletization.无定形和共无定形奥氮平在用于湿法制粒和制粒的制剂中的稳定性。
Int J Mol Sci. 2022 Sep 6;23(18):10234. doi: 10.3390/ijms231810234.
微乳液和微乳凝胶的开发,以增强蓬莪术提取物的经皮传递。
AAPS PharmSciTech. 2018 Jul;19(5):2058-2067. doi: 10.1208/s12249-018-1003-6. Epub 2018 Apr 23.
4
Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.共无定形活性药物成分-小分子混合物:增强溶解和口服生物利用度的共晶选择考虑因素。
J Pharm Sci. 2018 Jan;107(1):5-17. doi: 10.1016/j.xphs.2017.09.024. Epub 2017 Oct 5.
5
Preparation and characterization of amorphous ciprofloxacin-amino acid salts.无定形环丙沙星-氨基酸盐的制备与表征。
Eur J Pharm Biopharm. 2017 Dec;121:73-89. doi: 10.1016/j.ejpb.2017.09.009. Epub 2017 Sep 15.
6
Preparation of Chloramphenicol/Amino Acid Combinations Exhibiting Enhanced Dissolution Rates and Reduced Drug-Induced Oxidative Stress.制备氯霉素/氨基酸组合,提高溶解速率,降低药物诱导的氧化应激。
AAPS PharmSciTech. 2017 Nov;18(8):2910-2918. doi: 10.1208/s12249-017-0775-4. Epub 2017 Apr 20.
7
Arginine Complexes with Simvastatin: Apparent Solubility, In Vitro Dissolution and Solid State Characterization.精氨酸与辛伐他汀的复合物:表观溶解度、体外溶出度及固态表征
Curr Drug Deliv. 2018;15(1):77-86. doi: 10.2174/1567201814666170320144259.
8
Dissolution rate improvement of telmisartan through modified MCC pellets using 3 full factorial design.通过采用三因素全因子设计的改良微晶纤维素丸剂提高替米沙坦的溶出速率。
Saudi Pharm J. 2016 Sep;24(5):579-587. doi: 10.1016/j.jsps.2015.03.007. Epub 2015 Mar 23.
9
Development of a pharmaceutical cocrystal with solution crystallization technology: Preparation, characterization, and evaluation of myricetin-proline cocrystals.采用溶液结晶技术制备药物共晶体:杨梅素-脯氨酸共晶体的制备、表征与评价
Eur J Pharm Biopharm. 2016 Oct;107:151-9. doi: 10.1016/j.ejpb.2016.07.008. Epub 2016 Jul 6.
10
Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan.氨基酸作为共无定形辅料用于解决缬沙坦水溶性差的问题。
Pharm Dev Technol. 2017 Feb;22(1):69-76. doi: 10.3109/10837450.2016.1163390. Epub 2016 Apr 6.